Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 15/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL742294 | 0.93 | GPR119 (0.35) | GPR119OPRL1MAPTMEN1KMT2A | |
| SCHEMBL12733590 | 0.87 | GPR119 (0.39) | GPR119OPRL1MAPTMEN1KMT2A | |
| SCHEMBL742285 | 0.85 | OPRL1 (0.34) | GPR119OPRL1 | |
| SCHEMBL729414 | 0.84 | GPR119 (0.37) | GPR119OPRL1MAPTMEN1KMT2A | |
| SCHEMBL12621563 | 0.82 | CYP3A4 (0.36) | GPR119MAPTMEN1KMT2AGAA | |
| SCHEMBL1574943 | 0.80 | S1PR1 (0.31) | OPRL1MAPTGAA | |
| SCHEMBL1254835 | 0.80 | CYP3A4 (0.35) | GPR119MAPTMEN1KMT2AGAA | |
| SCHEMBL742207 | 0.76 | CYP3A4 (0.35) | GPR119 | |
| SCHEMBL732013 | 0.75 | OPRL1 (0.38) | OPRL1 | |
| SCHEMBL1818096 | 0.74 | OPRL1 (0.42) | GPR119OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394294-B2 | Four-ring liquid crystal compound having lateral fluorine, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20110090450-A1 | FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110090450-A1 | FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, LAS1L, EFHD2 | GPR119 3675/4885OPRL1 2073/4885MAPT 1075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.